1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6B8AF71761811527E0025891200443604
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/white-paper-how-medical-affairs-teams-can-improve-precision-speed-rwe-capabilities?opendocument
18
19opendocument
2018.97.9.169
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25RAS




» Products & Services » » Medical Affairs » Health Outcomes

White Paper: How Medical Affairs Teams Can Improve the Precision and Speed of Their RWE Capabilities

Whitepaper Image

ID: BEB-96


Pages/Slides: 7


Published: 2022


Delivery Format: PDF


 

License Options:


Download White Paper

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
The role of Medical Affairs in the real world data/evidence landscape is critical for strategic decision making, evaluating evidence gaps, developing clinical guidelines, shaping pricing and reimbursement policy, and interpreting the medical and clinical value of health outcomes. And as stakeholder expectations continues to evolve across the healthcare system, biopharma organizations are seeking innovative ways to utilize real world evidence to achieve maximum impact along patient, disease state, clinical, payer and other value fronts.

This trend is apparent in the actions taken by Medical Affairs groups across the industry, which are quickly implementing more formal RWE processes, pursuing innovation, and using RWE earlier in the product lifecycle.

Best Practices, LLC conducted benchmarking research – spotlighted in this white paper – to examine how Medical Affairs teams can improve the precision and speed of their RWE capabilities. The research establishes benchmarks around real world data sources, collection, evaluation, utilization, evidence generation, investment, and overall key performance indicators.

The findings and benchmarks examined in this white paper include:

  • Evolution of Real World Evidence Over the Years and Beyond
  • Real World Data – Sources, Collection and Evaluation
  • Medical Affairs RWE Team Structure, Reporting and Leadership
  • Real World Data Utilization and Evidence Generation
  • Real World Evidence Budget
  • Real World Evidence KPIs
Industries Profiled:
Consulting; Biotech; Medical Device; Pharmaceutical; Diagnostic; Clinical Research; Communications


Companies Profiled:
Pharma; Biotech; Medical Device Companies